Post by marykudro on Aug 25, 2021 7:51:23 GMT -5
Vedolizumab is sold under the brand name entyvio. It is a monoclonal antibody medication for treating ulcerative colitis and crohn,s disease. It is also used if you have tried other group of drug called anti-TNF but didn’t work for you. The recommended dose of Vedolizumab 108 mg injection should be given once every 2 weeks. The use of vedolizumab injection can be responsible for affecting the way patients respond to a vaccination. It is taken under the skin. Inform your doctor if you experience any allergic reaction. Side effects of vedolizumab 300 mg are usually mild and not life threatening.